InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Morningside Venture Investments Ltd, a TenPercentOwner, is a corporate insider tracked by InsiderTape across 5 companies. The public record shows 33 open-market SEC Form 4 transactions: 4 purchases worth $27.0M and 29 sales worth $21.3M, reported from Nov 18, 21 to Mar 29, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 29, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 29.0K | $30.45 | $885K |
| Mar 28, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 100.0K | $30.37 | $3.0M |
| Mar 27, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 33.0K | $30.80 | $997K |
| Mar 21, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 34.6K | $32.17 | $1.1M |
| Mar 16, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 9.1K | $32.55 | $297K |
| Mar 15, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 108.9K | $33.68 | $3.6M |
| Mar 14, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 70.7K | $34.54 | $2.4M |
| Mar 2, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 50.0K | $33.75 | $1.7M |
| Feb 23, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 48.9K | $36.24 | $1.7M |
| Feb 22, 23 | AMLXAmylyx Pharmaceuticals, Inc. | SELL | 47.9K | $36.34 | $1.7M |
| Feb 6, 23 | KZRKezar Life Sciences, Inc. | SELL | 40.0K | $6.88 | $275K |
| Feb 3, 23 | KZRKezar Life Sciences, Inc. | SELL | 25.0K | $7.15 | $179K |
| Feb 2, 23 | KZRKezar Life Sciences, Inc. | SELL | 50.0K | $7.19 | $360K |
| Feb 1, 23 | KZRKezar Life Sciences, Inc. | SELL | 40.0K | $6.95 | $278K |
| Jan 31, 23 | KZRKezar Life Sciences, Inc. | SELL | 30.0K | $7.08 | $212K |
| Jan 30, 23 | KZRKezar Life Sciences, Inc. | SELL | 30.0K | $6.91 | $207K |
| Jan 25, 23 | KZRKezar Life Sciences, Inc. | SELL | 50.0K | $6.85 | $343K |
| Jan 24, 23 | KZRKezar Life Sciences, Inc. | SELL | 80.0K | $6.98 | $558K |
| Jan 23, 23 | KZRKezar Life Sciences, Inc. | SELL | 80.0K | $6.81 | $545K |
| Jan 17, 23 | KZRKezar Life Sciences, Inc. | SELL | 6.1K | $6.79 | $42K |
| Jan 13, 23 | KZRKezar Life Sciences, Inc. | SELL | 2.0K | $7.15 | $14K |
| Jan 12, 23 | KZRKezar Life Sciences, Inc. | SELL | 5.0K | $6.77 | $34K |
| Jan 6, 23 | KZRKezar Life Sciences, Inc. | SELL | 3.0K | $6.89 | $21K |
| Jan 5, 23 | KZRKezar Life Sciences, Inc. | SELL | 12.2K | $6.97 | $85K |
| Jan 4, 23 | KZRKezar Life Sciences, Inc. | SELL | 30.0K | $7.17 | $215K |
| Jan 3, 23 | KZRKezar Life Sciences, Inc. | SELL | 500 | $7.10 | $4K |
| Dec 29, 22 | KZRKezar Life Sciences, Inc. | SELL | 25.0K | $7.10 | $178K |
| Oct 4, 22 | KZRKezar Life Sciences, Inc. | SELL | 3.6K | $8.82 | $32K |
| Oct 3, 22 | KZRKezar Life Sciences, Inc. | SELL | 28.7K | $8.78 | $252K |
| Aug 11, 22 | GRNAGreenLight Biosciences Holdings, PBC | BUY | 3.06M | $3.92 | $12.0M |
| Feb 2, 22 | ENVIGreenLight Biosciences Holdings, PBC | BUY | 1.00M | - | $0 |
| Jan 11, 22 | AMLXAmylyx Pharmaceuticals, Inc. | BUY | 263.2K | $19.00 | $5.0M |
| Nov 18, 21 | APLSApellis Pharmaceuticals, Inc. | BUY | 250.0K | $40.00 | $10.0M |